Call for more investment in cost-effective tuberculosis care
暂无分享,去创建一个
[1] E. McBryde,et al. Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countries , 2020, The Lancet regional health. Western Pacific.
[2] J. Richardus,et al. COVID-19 and Tuberculosis-Related Catastrophic Costs , 2020, The American journal of tropical medicine and hygiene.
[3] S. Bhatt,et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study , 2020, The Lancet Global Health.
[4] G. Marks,et al. Ending Tuberculosis by 2030 -pipe dream or reality? , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[5] G. Marks,et al. Household contact investigation for the detection of tuberculosis in Vietnam: economic evaluation of a cluster-randomised trial. , 2019, The Lancet. Global health.
[6] T. Wingfield,et al. Active case finding in tuberculosis-affected households: time to scale up. , 2019, The Lancet. Global health.
[7] G. Fox,et al. Passive case finding for tuberculosis is not enough , 2016, International journal of mycobacteriology.